info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Automated Cell Counters Market Analysis

ID: MRFR//10561-HCR | 128 Pages | Author: Rahul Gotadki| November 2024

The market dynamics of automated cell counters reflect a rapidly evolving landscape driven by technological advancements, rising demand for efficient cell counting solutions, and a growing focus on research and development in life sciences. Automated cell counters play a pivotal role in various fields, including biotechnology, pharmaceuticals, and clinical diagnostics, offering a streamlined and accurate approach to cell counting compared to traditional manual methods.

One key driver influencing the automated cell counters market is the increasing prevalence of diseases and the subsequent demand for advanced diagnostic tools. As researchers and healthcare professionals seek more precise and efficient ways to analyze cell samples, the adoption of automated cell counters has witnessed a notable upswing. These instruments provide not only rapid results but also reduce the chances of human error, ensuring the reliability of cell counting data.

Technological innovations have been a major catalyst in shaping the market dynamics. The integration of artificial intelligence and machine learning algorithms into automated cell counting systems has significantly enhanced their capabilities. This allows for more sophisticated and accurate analysis of diverse cell types, paving the way for personalized medicine and tailored treatment approaches. Additionally, the development of high-throughput automated cell counters has addressed the need for processing large volumes of samples in a time-efficient manner, further fueling market growth.

The competitive landscape of the automated cell counters market is characterized by the presence of established players and a surge in new entrants aiming to capitalize on the growing demand. Companies are actively investing in research and development to introduce innovative features, such as enhanced imaging technologies and connectivity options. This not only intensifies competition but also contributes to a continuous cycle of advancements, driving market expansion.

The pharmaceutical and biotechnology sectors are significant contributors to the demand for automated cell counters. These industries rely heavily on precise cell counting for various applications, including drug development, vaccine production, and bioprocessing. The need for standardized and reproducible results has led to a widespread adoption of automated cell counting solutions, creating a substantial market opportunity.

Moreover, the increasing focus on regenerative medicine and stem cell research has further propelled the demand for advanced cell counting technologies. Automated cell counters equipped with specialized algorithms for different cell types cater to the unique requirements of these cutting-edge fields. This expanding application scope broadens the market's horizons and presents manufacturers with lucrative prospects.

However, challenges such as the high initial cost of automated cell counters and the need for skilled personnel to operate these sophisticated instruments can potentially impede market growth. Addressing these challenges through strategic pricing models, user-friendly interfaces, and comprehensive training programs becomes crucial for market players to maximize their reach and impact.

Global Automated Cell Counters Market Overview


Automated Cell Counters Market Size was valued at USD 6.1 Billion in 2022. The Automated cell counters market industry is projected to grow from USD 6.4 Billion in 2023 to USD 10.1 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 5.80% during the forecast period (2023 - 2032).Rising incidence of chronic diseases, increased research activities, point-of-care testing (POCT), growing awareness of preventive healthcare, emerging markets, COVID-19 pandemic, customization and integration, are the key market drivers enhancing the market growth.


Automated Cell Counters Market Overview


Source: Secondary Research, Primary Research, MRFR Database and Analyst Review


Automated Cell Counters Market Trends



  • Rising incidence of chronic diseases is driving the market growth


One of the main factors propelling the market for automated cell counts is the rise in the prevalence of chronic diseases. Cancer, diabetes, cardiovascular disease, autoimmune disorders, and respiratory illnesses are examples of chronic diseases, which are distinguished by their protracted nature and frequently disabling effects. The need for precise, effective, and quick diagnostic technologies, like automated cell counters, has grown dramatically as these illnesses become more widespread worldwide.


To monitor illness progression, therapy effectiveness, and patient health in general for chronic diseases, regular monitoring is frequently necessary. By delivering quick and accurate assessments of blood cell counts, hemoglobin levels, and other hematological parameters, automated cell counters serve a crucial role in this respect. This improves the quality of care for patients with chronic diseases by assisting healthcare practitioners in making knowledgeable decisions and changing treatment programs as necessary.


Improved patient outcomes and less strain on healthcare systems may result from early diagnosis of chronic diseases. Automated cell counters make it possible to detect irregular blood cell counts early on, which can be a sign of more serious health problems. Early disease detection enables prompt treatment, which may stop or delay the progression of the disease and ultimately lower treatment expenses.


The COVID-19 pandemic highlighted the value of diagnostic methods in handling medical emergencies. Despite not being a chronic condition, COVID-19 highlighted the crucial role that automated cell counters play in evaluating patients' immunological responses, tracking the severity of the disease, and supporting therapeutic decision-making. Greater investments and demand for diagnostic technology have resulted from this greater knowledge of these tools. Thus, driving the automated cell counters market revenue.


Automated Cell Counters Market Segment Insights


Automated cell counters Product Type Insights


The automated cell counters market segmentation, based on product type, includes fluorescence image-based cell counter, flow cytometer and coulter counter. The coulter counter segment dominated the market in 2022. Coulter counters are recognized for their exceptional accuracy and precision when it comes to cell counting and sizing. They use the electrical impedance theory to calculate the volume of each cell as it passes through a microscopic hole. This accuracy is crucial since numerous applications, including clinical diagnosis and research, call for precise cell measurements.


Automated cell counters Application Insights


The automated cell counters market segmentation, based on Application, includes blood cells, cell lines, microbial cells and others. The blood cells segment dominated the market in 2022. Anemia, leukemia, lymphoma, and thrombocytopenia are among the hematological conditions that are on the rise worldwide. Blood cell counts are frequently necessary for these disorders to track the development of the disease, assess the effectiveness of treatment, and identify relapses. Automated cell counts are essential for controlling hematological illnesses because they produce accurate data quickly.


Figure 1: Automated Cell Counters Market, by Application, 2022 & 2032 (USD Billion)


Automated Cell Counters Market, by Application, 2022 & 2032


Source: Secondary Research, Primary Research, MRFR Database and Analyst Review


Automated cell counters End-use Insights


The automated cell counters market segmentation, based on end-use, includes pharmaceutical & biotechnology companies, hospitals, diagnostic laboratories, research institutes and others. The hospitals category generated the most income in 2022. This is because automated cell counters are in high demand in clinical laboratories for blood analysis. Blood cells must be counted and analyzed by automated cell counters in order to diagnose and treat a range of blood illnesses.


Automated cell counters Regional Insights


By region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. The North America Automated Cell Counters Market dominated this market in 2022 (45.80%). North America is the world leader in biomedical research and development. The region is home to a large number of pharmaceutical enterprises, biotech companies, and academic research centers for drug discovery, clinical trials, and fundamental research. This ongoing research activity fuels the demand for better cell counting machinery. Further, the U.S. Automated cell counters market held the largest market share, and the Canada Automated cell counters market was the fastest growing market in the North America region.


Further, the major countries studied in the market report are The U.S., Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.


Figure 2: AUTOMATED CELL COUNTERS MARKET SHARE BY REGION 2022 (USD Billion)


AUTOMATED CELL COUNTERS MARKET SHARE BY REGION 2022


Source: Secondary Research, Primary Research, MRFR Database and Analyst Review


Europe Automated cell counters market accounts for the second-largest market share. Public health projects focused at disease prevention and early detection are frequently started by European governments and healthcare institutions. These initiatives can include screenings that use computerized cell counters to find those at risk for different illnesses. Further, the German Automated cell counters market held the largest market share, and the UK Automated cell counters market was the fastest growing market in the European region.


The Asia-Pacific Automated Cell Counters Market is expected to grow at the fastest CAGR from 2023 to 2032. Both densely populated urban areas and isolated rural areas make up Asia Pacific's enormous and diversified population. In order to meet a wide range of medical demands, the sheer size of the population generates a significant demand for healthcare services, including diagnostic equipment like automated cell counters. Moreover, China’s automated cell counters market held the largest market share, and the Indian Automated cell counters market was the fastest growing market in the Asia-Pacific region.


Automated Cell Counters Key Market Players & Competitive Insights


Leading market players are investing heavily in research and development in order to expand their product lines, which will help the automated cell counters market, grow even more. Market participants are also undertaking a variety of strategic activities to expand their footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, automated cell counters industry must offer cost-effective items.


Manufacturing locally to minimize operational costs is one of the key business tactics used by manufacturers in the automated cell counters industry to benefit clients and increase the market sector. In recent years, the automated cell counters industry has offered some of the most significant advantages to medicine. Major players in the Automated cell counters market, including Eppendorf, Thermo Fischer Scientific, Countstar Inc., Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd, Chemometec A/S, ALIGNEDGENETICS, Beckman Coulter, Inc. (Danaher), Nanoentek, Olympus Corporation, MERCK KGaA, Sysmex Corporation, Agilent Technologies, Inc., Abbott, Nexcelom Bioscience LLC and others, are attempting to increase market demand by investing in research and development operations.


Thermo Fisher Scientific Inc. (Thermo Fisher) delivers medical equipment, analytical instruments, reagents and consumables, software, and services to satisfy the demands of challenging analytical challenges in research, diagnostics, and clinical laboratories. It offers solutions for cellular biology, synthetic biology, and flow cytometry. Mass spectrometry, genetic sequencing, electron microscopy, protein, and molecular biology research equipment are just a few of the many products that the company sells. The company offers services to companies in the environmental, industrial quality, and process control sectors, as well as to academic and research institutes, governmental organizations, pharmaceutical and biotech companies, clinical diagnostic laboratories, and environmental companies. It provides its products and services through its direct sales force, online sales, and third-party distributors across the Americas, Asia-Pacific, and Europe. The headquarters of Thermo Fisher are located in Waltham, Massachusetts, in the US.


Abbott Laboratories (Abbott) discovers, develops, manufactures, and sells a wide range of healthcare products, including branded generic drugs, diagnostic devices, and infant, child, and adult nutritional supplements. Additionally, the company sells a variety of medical devices, including those for heart failure, neuromodulation, electrophysiology, rhythm management, and vascular and structural cardiac devices. Additionally, the company offers nutritional products, minerals, and dietary supplements. It has production facilities all around the world and R&D facilities in the US, China, Colombia, India, Singapore, Spain, and the UK. Africa, the Middle East, Latin America, North America, and the Asia-Pacific area are among the regions where the firm sells its products. Abbott is based in Abbott Park, Illinois, a city in the US.


Key companies in the automated cell counters market include



  • Eppendorf

  • Thermo Fischer Scientific

  • Countstar, Inc.

  • Bio-Rad Laboratories, Inc.

  • F. Hoffmann-La Roche Ltd

  • Chemometec A/S

  • ALIGNEDGENETICS

  • Beckman Coulter, Inc. (Danaher)

  • Nanoentek

  • Olympus Corporation

  • MERCK KGaA

  • Sysmex Corporation

  • Agilent Technologies, Inc.

  • Abbott

  • Nexcelom Bioscience LLC


Automated cell counters Industry Developments


March 2022:The complete blood count (CBC) and erythrocyte sedimentation rate (ESR) tests are included in Mindray's new BC-700 Series of hematology analyzers.


February 2022:Abacus dx and Luminex have formed a new agreement for the Guava line of flow cytometry tools and supplies. As part of the agreement, Abacus dx will sell Luminex's Guava line of flow cytometry tools and supplies.


June 2022:The FAD approved the Sysmex Corporation's XN-10 hematological analyzer with blood bank mode. A highly developed automated hematology analyzer called the XN-10 is used to count white blood cells.


Automated Cell Counters Market Segmentation


Automated Cell Counters Product Type Outlook



  • Fluorescence image-based cell counter

  • Flow cytometer

  • Coulter counter


Automated Cell Counters Application Outlook

  • Blood Cells

  • Cell lines

  • Microbial cells

  • Others


Automated Cell Counters End-use Outlook



  • Pharmaceutical & biotechnology companies

  • Hospitals

  • Diagnostic laboratories

  • Research institutes

  • Others


Automated Cell Counters Regional Outlook



  • North America

    • U.S.

    • Canada



  • Europe

    • Germany

    • France

    • UK

    • Italy

    • Spain

    • Rest of Europe



  • Asia-Pacific

    • China

    • Japan

    • India

    • Australia

    • South Korea

    • Australia

    • Rest of Asia-Pacific



  • Rest of the World

    • Middle East

    • Africa

    • Latin America



Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.